Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Acupunct Meridian Stud ; 5(5): 234-40, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23040104

ABSTRACT

Molecular-level understanding of the structure and the functions of the lymphatic system has greatly enhanced the importance of this second circulation system, especially in connection with cancer metastasis and inflammation. Recently, a third circulatory system, the primo vascular system (PVS) was found in various parts of an animal's body, especially as threadlike structures floating in the lymphatic flow in lymph vessels. Although the medical significance of this emerging system will require much work in the future, at present, several important suggestions in connection with immune cells, stem cells, and cancer metastasis have already appeared. Experiments to observe the PVS in the lymph vessels near the caudal vena cava of rabbits and rats have been performed by several independent teams, but reproduction requires considerable skill and technical know-how. In this article, we provide a detailed protocol to detect the PVS inside the lymph vessels of a rabbit. Detection and isolation are the first steps in unraveling the physiological functions of the PVS, which awaits intensive research.


Subject(s)
Acupuncture Points , Lymphatic Vessels/anatomy & histology , Meridians , Microscopy/methods , Staining and Labeling/methods , Alcian Blue/chemistry , Animals , Female , Lymphatic Vessels/chemistry , Rabbits
2.
Yonsei Med J ; 48(5): 839-46, 2007 Oct 31.
Article in English | MEDLINE | ID: mdl-17963343

ABSTRACT

PURPOSE: Herniated nucleus pulposus fragments are recognized by the immune system as a foreign-body, which results in an autoimmune reaction. Human activation-inducible tumor necrosis factor receptor (AITR) and its ligand, AITRL, are important costimulatory molecules in the pathogenesis of autoimmune diseases. Despite the importance of these costimulatory molecules in autoimmune disease, their role in the autoimmune reaction to herniated disc fragments has yet to be explored. The purpose of the present study is to investigate whether the overexpression of AITR and AITRL might be associated with lumbar disc herniation. MATERIALS AND METHODS: The study population consisted of 20 symptomatic lumbar disc herniation patients. Ten macroscopically normal control discs were obtained from patients with spinal fractures managed with anterior procedures that involved a discectomy. Peripheral blood samples from both the study patients and controls were collected. The expression levels of AITR and AITRL were investigated by flow cytometric analysis, confocal laser scanning microscopy, immunohistochemistry and by reverse transcriptase-polymerase chain reaction (RT-PCR). The soluble AITR and AITRL serum levels were measured by an enzyme-linked immunosorbent assay. RESULTS: Flow cytometric analysis revealed significantly higher levels of both AITR and AITRL in the lumbar disc herniation patients than in the controls. The AITRL expression levels were also increased in patients with lumbar disc herniation, shown by using confocal laser scanning microscopy, immunohisto-chemistry, and RT-PCR. Finally, soluble AITR and AITRL were elevated in the patients with lumbar disc herniations. CONCLUSION: The AITR and AITRL are increased in both the herniated disc tissue and the peripheral blood of patients with lumbar disc herniation.


Subject(s)
Intervertebral Disc Displacement/immunology , Lumbar Vertebrae , Receptors, Nerve Growth Factor/blood , Receptors, Tumor Necrosis Factor/blood , Tumor Necrosis Factors/blood , Adult , Female , Flow Cytometry , Glucocorticoid-Induced TNFR-Related Protein , Humans , Immunohistochemistry , Interleukins/blood , Male , Microscopy, Confocal , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/blood
3.
J Bone Miner Res ; 21(12): 1907-12, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17002586

ABSTRACT

UNLABELLED: Enhanced osteoclastogenesis was observed in bone marrow-derived macrophage cells from 4-1BB-deficient mice than in those from wildtype mice. 4-1BB and 4-1BB ligand interaction may play a role at a certain stage of osteoclast formation through increased level of IL-10, a negative regulator of osteoclastogenesis. INTRODUCTION: 4-1BB is an inducible T-cell costimulatory molecule and a member of the TNF receptor family. The expression pattern of 4-1BB and 4-1BB ligand (4-1BBL) has suggested that 4-1BB plays a role not only in various responses related to innate immunity but also in bone metabolism. MATERIALS AND METHODS: Osteoclast formation was evaluated in bone marrow-derived macrophage cells (BMMs) from wildtype and 4-1BB-deficient (4-1BB-/-) mice. Expression of interleukin-10 (IL-10) during osteoclast formation was analyzed at the mRNA and protein levels. RESULTS: Expression of IL-10 was higher in RANKL-stimulated wildtype BMMs than 4-1BB-/- BMMs. When 4-1BBL was stimulated with 4-1BB-Fc fusion protein, the expression of IL-10 in BMMs increased. Neutralization of IL-10 was not as effective in preventing inhibition by IL-10 of osteoclast differentiation in 4-1BB-/- BMMs as in wildtype BMMs. When IL-10 was added to the culture medium, osteoclast formation was inhibited more efficiently in the 4-1BB-/- BMMs than in the wildtype BMMs. CONCLUSIONS: Interaction of 4-1BB and 4-1BBL stimulates IL-10 production through 4-1BBL signaling. 4-1BBL plays a role at a certain stage of osteoclast formation, and IL-10 may mediate this effect. The elevated level of osteoclastogenesis in 4-1BB-/- BMMs may thus be caused, in part, by a lower level of IL-10.


Subject(s)
4-1BB Ligand/metabolism , Cell Differentiation , Interleukin-10/metabolism , Osteoclasts/metabolism , Signal Transduction , Tumor Necrosis Factor Receptor Superfamily, Member 9/metabolism , Animals , Cell Differentiation/genetics , Mice , Signal Transduction/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 9/deficiency
4.
Article in English | MEDLINE | ID: mdl-16511253

ABSTRACT

The 4-1BB ligand, a member of the tumour necrosis factor (TNF) family, is an important co-stimulatory molecule that plays a key role in the clonal expansion and survival of CD8+ T cells. Signalling through binding of the 4-1BB ligand and 4-1BB has been reported to enhance CD8+ T-cell expansion and protect activated CD8+ T cells from death. The 4-1BB ligand is an integral protein expressed on activated antigen-presenting cells. The extracellular domain of the 4-1BB ligand fused with glutathione-S-transferase was expressed in Escherichia coli (Origami) and purified by using affinity and ion-exchange column chromatographic methods. Crystals of the 4-1BB ligand were obtained at 290 K by the hanging-drop vapour-diffusion method. X-ray diffraction data were collected from these crystals to 2.8 A resolution and the crystals belong to space group C2, with unit-cell parameters a = 114.6, b = 73.8, c = 118.50 A, beta = 115.5 degrees.


Subject(s)
Extracellular Space/chemistry , Tumor Necrosis Factors/chemistry , 4-1BB Ligand , Crystallization , Crystallography, X-Ray , Extracellular Space/genetics , Humans , Multigene Family , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Tumor Necrosis Factors/genetics
5.
Exp Mol Med ; 38(6): 606-15, 2006 Dec 31.
Article in English | MEDLINE | ID: mdl-17202836

ABSTRACT

Our previous study has demonstrated that there is a significant delay of Balb/c cardiac allograft rejection in the C57BL/6 4-1BB-deficient knockout recipient. In this study, we examined the effect of combined blockade of the 4-1BB and CD28 costimulatory pathways on cardiac allograft rejection in the C57BL/6-->Balb/c model. A long-term cardiac allograft survival was induced in CD28/4-1BB- deficient mice (>100 days survival in 3 of 4 mice), which was comparable with CD28-deficient mice (>100 days survival in 2 of 5 mice; P<0.2026). There was no long-term cardiac allograft survival in either wild-type (WT) or 4-1BB-deficient mice, even though 4-1BB-deficient recipients showed a significant delay of cardiac allograft rejection than WT mice. An in vitro mixed leukocyte reaction (MLR) assay showed that 4-1BB-deficient and WT mouse T cells had a similar responsiveness to allostimulation, whereas CD28- and CD28/4-1BB-deficient mouse T cells had a defective responsiveness to allostimulation. Furthermore, 4-1BB-deficient mice showed a similar CTL but an elevated Ab response against alloantigens as compared to WT mice, and the alloimmune responses of 4-1BB-deficient mice were abrogated in the CD28-deficient background. Overall, these results indicate that the CD28 costimulatory pathway plays a major role in the alloimmune response and that 4-1BB signals are dependent upon CD28 signals.


Subject(s)
4-1BB Ligand/immunology , CD28 Antigens/immunology , Signal Transduction/immunology , 4-1BB Ligand/deficiency , 4-1BB Ligand/genetics , 4-1BB Ligand/metabolism , Animals , Antibodies/immunology , CD28 Antigens/genetics , CD28 Antigens/metabolism , Cytotoxicity Tests, Immunologic , Graft Survival/immunology , Heart Transplantation/immunology , Isoantigens/immunology , Mice , Mice, Knockout , Transplantation, Homologous/immunology
6.
J Immunol Methods ; 286(1-2): 187-201, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15087232

ABSTRACT

Given the key role 4-1BB plays in the stimulation of T cells, humanization of agonistic anti-human 4-1BB monoclonal antibody (mAb) may have important clinical applications. In this paper, we present the humanization of agonistic anti-human 4-1BB mAb, BBK-4, using a phage display library. We first prepared the combinatorial library by incorporating murine and human alternative at positions representing buried residues that might affect the structural integrity of the antigen binding site. Six humanized single chain Fv (scFv) fragments were selected from the combinatorial library expressing phage-displayed humanized scFv. They were found to retain the epitope specificity of the original mAb but had affinities of lower than 1/10 of the original. In spite of the lower affinity, the humanized scFv coated on the surface expanded human peripheral blood mononuclear cells (PBMCs) in MLR similarly to the original mAb in the presence of anti-CD3 mAb. These results suggest that humanized anti-human 4-1BB scFvs can be used as a valuable reagent for clinical application.


Subject(s)
Antibodies, Monoclonal/immunology , Immunoglobulin Variable Region/immunology , Receptors, Nerve Growth Factor/agonists , Receptors, Nerve Growth Factor/immunology , Receptors, Tumor Necrosis Factor/agonists , Receptors, Tumor Necrosis Factor/immunology , Amino Acid Sequence , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/genetics , Antigens, CD , Base Sequence , DNA/chemistry , DNA/genetics , Enzyme-Linked Immunosorbent Assay , Escherichia coli/genetics , Flow Cytometry , Gene Library , Humans , Immunoglobulin Variable Region/genetics , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-4/immunology , Interleukin-4/metabolism , Kinetics , Molecular Sequence Data , Peptide Library , Polymerase Chain Reaction , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Sequence Alignment , Surface Plasmon Resonance , Tumor Necrosis Factor Receptor Superfamily, Member 9
7.
Exp Mol Med ; 36(1): 13-22, 2004 Feb 29.
Article in English | MEDLINE | ID: mdl-15031666

ABSTRACT

Rheumatoid arthritis (RA) is a multifactorial autoimmune disease whose etiopathogenesis is not well understood. Although soluble (s) forms of 4-1BB (s4-1BB) and 4-1BB legand (s4-1BBL) have been detected in the sera of RA patients, their significance is not known. We compared the serum levels of s4-1BB and s4-1BBL in RA patients with those in systemic lupus erythematosus (SLE) and Behcet's disease (BD) patients. Serum levels of s4-1BB and s4-1BBL were significantly higher in RA patients compared with healthy controls, SLE or BD patients, and the abundance was correlated with disease severity in patients with RA. The serum levels of s4-1BB in RA patients were inversely corroborated with 4-1BB expression levels on activated T lymphocytes. In addition, there was a correlation between serum levels of s4-1BB and s4-1BBL. The augmented secretion of s4-1BB and s4-1BBL levels into the serum may reflect the clinical symptoms of RA and levels of s4-1BB and s4-1BBL in sera at the time of diagnosis may be indicative of the severity and outcome of RA.


Subject(s)
Arthritis, Rheumatoid/blood , Arthritis, Rheumatoid/pathology , Receptors, Nerve Growth Factor/blood , Receptors, Tumor Necrosis Factor/blood , Tumor Necrosis Factor-alpha/metabolism , 4-1BB Ligand , Adult , Aged , Antigens, CD/metabolism , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/immunology , Behcet Syndrome/blood , Behcet Syndrome/immunology , Female , Humans , Immunosuppressive Agents/metabolism , Immunosuppressive Agents/therapeutic use , Leukocytes, Mononuclear/metabolism , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/immunology , Male , Middle Aged , Random Allocation , Severity of Illness Index , Statistics as Topic , Tumor Necrosis Factor Receptor Superfamily, Member 9
8.
Exp Mol Med ; 35(3): 154-9, 2003 Jun 30.
Article in English | MEDLINE | ID: mdl-12858013

ABSTRACT

By searching an EST database, we identified two TNF receptor superfamily members (named mTNFRH1 and mTNFRH2). Amino acid sequences are highly conserved between the two receptors (78% identity). The chromosomal loci of mTnfrh1 and mTnfrh2 genes are found in distal chromosome 7 in the mouse. mTNFRH1 and mTNFRH2 do not contain the cytoplasmic domain, indicating that they might function as decoy receptors. Furthermore, an alternatively spliced form of mTNFRH1 was found which contains neither the transmembrane domain nor the cytoplasmic domain, thus presumably existing as a soluble form. Northern blot analysis showed that mTnfrh1 mRNA was negligibly expressed in tissues, while mTnfrh2 mRNA was strongly expressed in spleen, lung, liver, kidney, and testis. When the extracellular domains of mTNFRH1 and mTNFRH2 were expressed in bacteria, their molecular weight of extracellular region was approximately 15 kDa. Both of the soluble forms were effective in inhibiting T-cell proliferation stimulated by anti-CD3 monoclonal antibody. Our data suggest that mTNFRH1 and mTNFRH2 may be implicated in exerting a modulatory role in the immune response.


Subject(s)
Cell Division/physiology , Receptors, Tumor Necrosis Factor/biosynthesis , Recombinant Proteins/biosynthesis , T-Lymphocytes/cytology , Alternative Splicing/genetics , Amino Acid Sequence , Animals , Base Sequence , Databases, Nucleic Acid , Gene Expression/genetics , Mice , Molecular Sequence Data
9.
Exp Mol Med ; 35(1): 8-16, 2003 Feb 28.
Article in English | MEDLINE | ID: mdl-12642898

ABSTRACT

Current therapies for autoimmune diseases are not cures but merely palliatives, aimed at reducing symptoms. For the most part, these treatments provide nonspecific suppression of the immune system and thus do not distinguish between a pathogenic autoimmune response and a protective immune response. Recently emerging evidence not only has indicated the involvement of members of the TNF receptor/ligand superfamilies but also has revealed exciting innovative strategies for the treatment of autoimmune diseases and other chronic inflammatory diseases without depressing the immune response in general. In this review, we will discuss the regulatory mechanisms of TNF receptor/ligand family members, such as HVEM/ LIGHT, 4-1BB/4-1BBL, and GITR/GITRL that regulate T and B cell functions and participate in the process of inflammatory diseases. We will also discuss how intervening in the costimulatory pathways mediated by these molecules might have some potential as a therapeutic approach to immune disorders.


Subject(s)
Inflammation/immunology , Receptors, Tumor Necrosis Factor/physiology , Tumor Necrosis Factor-alpha/physiology , Animals , Apoptosis , Autoimmune Diseases/immunology , Autoimmune Diseases/metabolism , Autoimmune Diseases/pathology , B-Lymphocytes/immunology , B-Lymphocytes/physiology , Dendritic Cells/physiology , Humans , Lymphocyte Activation/immunology , Models, Biological , T-Lymphocytes/immunology , T-Lymphocytes/physiology , Tumor Necrosis Factor-alpha/immunology
10.
Exp Mol Med ; 35(6): 501-8, 2003 Dec 31.
Article in English | MEDLINE | ID: mdl-14749527

ABSTRACT

Herpes virus entry mediator (HVEM) is a newly discovered member of the tumor necrosis factor receptor (TNFR) superfamily that has a role in herpes simplex virus entry, in T cell activation and in tumor immunity. We generated mAb against HVEM and detected soluble HVEM (SHVEM) in the sera of patients with various autoimmune diseases. HVEM was constitutively expressed on CD4(+) and CD8(+) T cells, CD19(+) B cells, CD14(+) monocytes, neutrophils and dendritic cells. In three-way MLR, mAb 122 and 139 were agonists and mAb 108 had blocking activity. An ELISA was developed to detect sHVEM in patient sera. sHVEM levels were elevated in sera of patients with allergic asthma, atopic dermatitis and rheumatoid arthritis. The mAbs discussed here may be useful for studies of the role of HVEM in immune responses. Detection of soluble HVEM might have diagnostic and prognostic value in certain immunological disorders.


Subject(s)
Autoimmune Diseases/blood , Hypersensitivity/blood , Receptors, Tumor Necrosis Factor/blood , Receptors, Virus/blood , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Arthritis, Rheumatoid/blood , Arthritis, Rheumatoid/immunology , Asthma/blood , Asthma/immunology , Autoimmune Diseases/immunology , Cell Division , Cell Line , Dermatitis, Atopic/blood , Dermatitis, Atopic/immunology , Female , Flow Cytometry , Humans , Hypersensitivity/immunology , Lymphocyte Culture Test, Mixed , Mice , Mice, Inbred BALB C , Receptors, Tumor Necrosis Factor/immunology , Receptors, Tumor Necrosis Factor, Member 14 , Receptors, Virus/immunology , Solubility
11.
Life Sci ; 70(21): 2535-45, 2002 Apr 21.
Article in English | MEDLINE | ID: mdl-12173416

ABSTRACT

Macrophage inflammatory protein-related protein-2 (MRP-2) is a new member of the CC chemokine family that is recently identified in murine macrophages. MRP-2 is involved in leukocyte trafficking and activation, which can be implicated in inflammatory diseases including atherosclerosis. Little is known about the involvement of this novel chemokine MRP-2 in the pathogenesis of atherosclerosis. To explore the possible association of the MRP-2 with atherosclerosis, we investigated the effects of atherogenic diet on MRP-2 expression in mice. Male C57BL/6 mice were fed a high fat and cholesterol diet (20% fat and 1.5% cholesterol) or a control diet based on AIN-76 for 5, 10, or 14 weeks. The levels of total cholesterol, LDL cholesterol, and F2-isoprostanes in plasma were measured using appropriate enzymatic assays. Tumor necrosis factor alpha (TNF alpha) and MCP-1 release by peritoneal macrophages was determined by ELISA. The mRNA expression level of the MRP-2 was measured by RT-PCR. The levels of total cholesterol, LDL-cholesterol, and 8-iso-prostaglandin F2 alpha in plasma, well-known indexes of atherosclerosis, were significantly increased in the high fat and cholesterol diet group compared to those in the control. A significant increase in the TNF alpha and MCP-1 production by macrophages was also observed in the group fed high fat and cholesterol diet. The mRNA expression of MRP-2 was upregulated by oxLDL treatment in vitro and feeding a high fat and cholesterol diet in vivo at the late stage of atherosclerosis. These results suggest that MRP-2 may be an important contributing factor in the development of atherosclerosis.


Subject(s)
Cytokines/metabolism , Dietary Fats/administration & dosage , Macrophage Inflammatory Proteins , Animals , Arteriosclerosis/pathology , Arteriosclerosis/prevention & control , Chemokine CCL2/biosynthesis , Chemokines, CC , Cholesterol, LDL/blood , Enzyme-Linked Immunosorbent Assay , Isoprostanes/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Male , Mice , Mice, Inbred C57BL , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/biosynthesis , Up-Regulation/drug effects
12.
Cancer Biother Radiopharm ; 17(2): 193-203, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12030113

ABSTRACT

A QSAR analysis of the anti-tumor, anti-metastasis and anti-colony formation (for metastatic colonies) activities of eighteen nitroazoles (including metronidazole and hypoxic radiosensitizers RP-170, KU-2285 and sanazole (drug AK-2123)) and their nitro and nitroso anion radical derivatives against melanoma B16 in mice has been performed. The QSAR models were built with the use of the frontal polygon method. This approach has features of different 3D QSAR methodologies and belongs to the group of "indirect" methods. The procedure allows to build robust models with high predictive ability even in series of diverse and conformationally flexible compounds. Key atomic characteristics accompany the geometrical requirements in the analysis of local 3D molecular similarity. By variation of weight coefficients for hydrophobicity, refraction increments, and partial charge it is possible to achieve better quality of QSAR and evaluate the importance of each characteristic for biological activity under consideration. It was found that hydrophobicity, molar refraction and charge characteristics of nitro anion radical derivatives are more significant for interaction with molecular targets than those of the parent compounds and of the nitroso anion radical derivatives. Size and hydrophobic properties of substituents in nitro anion radicals play significant role for ligand-target interaction in the processes of inhibition of metastatic spreading and growth of metastatic colonies by nitroazoles. A scheme of competitive interaction of parent nitroazoles and their anion radicals with a target in organism is suggested. It can be concluded that the step of one-electron reduction of nitroazoles can be important for anticancer activity of these drugs.


Subject(s)
Antineoplastic Agents/pharmacokinetics , Azoles/pharmacokinetics , Free Radicals/chemistry , Melanoma, Experimental/drug therapy , Nitro Compounds/pharmacokinetics , Animals , Antineoplastic Agents/pharmacology , Azoles/pharmacology , Colony-Forming Units Assay , Melanoma, Experimental/secondary , Mice , Models, Molecular , Nitro Compounds/pharmacology , Quantitative Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...